This study investigated the effects of propofol on primary neuronal cultures from rat embryos. Primary cortical neuronal cultures were prepared from Wistar rat embryos (E18). The viability of cells exposed to 0.01, 0.1 or 1 mg/ml propofol for up to 48 h was assessed using a methyltetrazolium assay. In order to evaluate the role of g-aminobutyric acid-A (GABA A ) receptors, cells were also preincubated with the GABA A -receptor antagonists, gabazine and picrotoxin. Propofol at a concentration of 1 mg/ml significantly reduced cell viability after 12 h. In contrast, this concentration led to a significant increase in cell viability at 3 and 6 h. The GABA A -receptor antagonists did not influence the neurodegenerative effect of propofol but abolished its neuroprotective effect. DNA fragmentation as a marker of apoptosis was elevated after 24 h propofol treatment. These results confirm that high doses of propofol can cause GABA Areceptor triggered neuroprotection and a subsequent time-dependent, but GABA Aindependent, neurodegeneration in primary cortical neurons.
Introduction
There is an indisputable need for general anaesthesia in newborns and infants undergoing diagnostic or surgical interventions. The increasing complexity in the combination of sedative, anxiolytic and analgesic drugs used is, however, contradictory to the current state of research knowledge about the effects of these agents.
The findings of Ikonomidou et al. 1 in 2000 confirmed the suspicion that induction of neurodegeneration in the embryonic brain could be triggered via N-methyl-D-aspartate (NMDA)-receptor antagonists and *M Berns and L Seeberg contributed equally to this study.
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γ-aminobutyric acid-A (GABA A )-receptor agonists. 1 Since then, neurodegenerative effects have been demonstrated for various anaesthetic agents, including ketamine, barbiturates, midazolam, isoflurane, nitrous oxide and propofol, 2 -5 which are thought to act via GABA A agonism and/or glutamate antagonism. 6 It has become clear that the neurodegenerative effects of anaesthetics are dependent on when they are administered. 7 The strongest effect was observed when anaesthetics were applied during the brain growth spurt. 8 During this stage of development, crucial structural alterations occur, such as the formation of neural connections and dendritic and axonal maturation, as well as physiological apoptosis. This period spans from the third trimester of pregnancy to several years after birth in humans, 5 whereas in rodents it corresponds to the first three post-natal weeks. 1, 5, 9 Propofol, an alkyl phenol derivate dissolved in a lipid emulsion, was introduced as an anaesthetic agent in 1977 10 and is widely used for intravenous induction and maintenance of a surgical plane in paediatric anaesthesia. Even though its use for sedation in critical care has been restricted following reports of children dying from myocardial failure after long-term propofol infusion, 11 its application in children older than 2 months for the maintenance of anaesthesia is considered to be safe. 12 Despite these restrictions, the offlabel use of propofol anaesthesia is common even in pre-term infants and neonates.
The uncertainty surrounding the safety of the anaesthetics used in neonatal anaesthesia highlights the importance of further investigations. In view of the complexity of validation of anaesthesia for humans in clinical practice, in vitro models are useful tools to examine the potential adverse effects of pharmacological agents during brain development.
The aim of this study was to investigate the effects of propofol on the survival of primary neuronal cells from rat embryos and to elucidate its mechanisms of action during the developmental period, including the possible role of GABA A receptors.
Materials and methods

PRIMARY CORTICAL NEURONAL CULTURE
All procedures were performed according to the local guidelines for animal research approved by the Charité-Universitätsmedizin Berlin. Primary neuronal cultures were prepared as described elsewhere. 13 Briefly, cerebral cortices from Wistar rat embryos (E18) (Centre for Experimental Medical Research, Charité-Universitätsmedizin Berlin) were dissected in serum-free neurobasal medium with B27 supplement (Gibco-Invitrogen, Karlsruhe, Germany) and the meninges were removed. 13, 14 After trypsinization for 15 min at 37°C in trypsin/ethylenediaminetetra-acetic acid (0.05/0.02%) in phosphate-buffered saline (1 mM KH 2 PO 4 , 155 mM NaCl, 2.96 mM Na 2 HPO 4 ·7H 2 O, pH 7.4; Biochrom, Berlin Germany), the fragments were rinsed twice with phosphate-buffered saline and once with dissociation medium (neurobasal medium with 2% B27 supplement, 1% penicillin and streptomycin and 1% Lglutamine), and then subjected to mechanical dissociation by repeated aspirations through a fire-polished Pasteur pipette in dissociation medium. The cell suspension was pelleted by centrifugation (1200 rpm) for 2 min at room temperature (Minifuge GL; Heraeus Instruments, Fellbach, Germany) and seeded in flatbottomed wells in neurobasal medium with B27 supplement containing L-glutamine, M Berns, L Seeberg, M Schmidt et al.
Effects of propofol on neuronal cells
penicillin and streptomycin at a density of 3 × 10 6 cells/ml. Prior to cell plating, wells were treated with poly-D-lysine (0.5% in water; Sigma, St Louis, MO, USA) for 1 h at room temperature and rinsed twice with water. Cells were stored in a fully humidified incubator at 37°C with 5% CO 2. After 7 days in vitro, 50% of the medium was removed and replaced with fresh medium.
CELL TREATMENTS
After a total of 15 days in vitro, cells were then exposed in three series to 0.01, 0.1 or 1 mg/ml propofol for 3, 6, 9, 12, 24 and 48 h or to an equivalent dose of the vehicle (ClinOleic; Baxter, Heidelberg, Germany). Control cells remained untreated. All plates were placed in the same incubator.
To explore the influence of GABA A receptors, untreated cell plates were preincubated with the GABA A -receptor antagonists gabazine (0.1 mM) and picrotoxin (0.1 mM) for 30 min. These cultures were then exposed to 1 mg/ml propofol and either gabazine (0.1 mM) or picrotoxin (0.1 mM).
CELL VIABILITY ASSAY
The methyltetrazolium (MTT) assay, based on reduction of the tetrazolium salt 3-(4,5dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (Sigma) to coloured formazan by active dehydrogenases within live mitochondria, was used to determine cell viability. 15 Neuronal cells were plated onto 96-well plates coated with poly-D-lysine in 100 µl aliquots (60 000 cells/well) and treated as described above. Control cells were kept in neurobasal medium. After 3, 6, 9, 12, 24 and 48 h, 10 µl MTT at a final concentration of 0.5 mg/ml was added for 2 h. Insoluble purple formazan grains were solubilized by adding 100 µl of 10% sodium dodecyl sulphate and 0.01 M HCl. Absorbances at 570 nm and the reference wavelength 630 nm were measured using a microplate reader (Bio-Rad Laboratories, Munich, Germany).
LIGHT PHASE CONTRAST PHOTOMICROGRAPHS
To visualize the cell damage caused by propofol (1 mg/ml), representative photomicrographs were taken of exposed and control cultures using an Olympus digital camera (Olympus, Tokyo, Japan) with a ×40 objective lens.
DETECTION OF CELL DEATH
To quantify apoptosis and necrosis, histonecomplexed DNA fragments from the cytoplasm of apoptotic cells or released from necrotic cells were detected using an enzymelinked immunoassay (ELISA) and quantified spectrophotometrically. After incubation of the cells with propofol as described above, 20 µl cell incubating medium containing DNA from necrotic cells that had leaked through the membrane during incubation was transferred to a streptavidin-coated well. The remaining medium was discarded. To determine the amount of apoptotic nucleosomes, the apoptotic cells were lysed and centrifuged, and an aliquot of the supernatant was transferred to a streptavidin-coated well. The oligosomal DNA was quantified using Cell Death Detection ELISA PLUS (Roche Diagnostics, Grenzach-Wyhlen, Germany) according to the manufacturer's protocol. Results were expressed as absorbance of the supernatant of the lysate or the incubating medium of the propofol-treated cells against that of untreated cells as controls.
STATISTICAL ANALYSIS
Data were presented as means ± SEM. Statistical comparisons between the normal distributed groups were performed using analysis of variance and the Bonferroni post- 
Results
CELL VIABILITY AFTER PROPOFOL TREATMENT
Cell viability after propofol treatment, given as the percentage change in cell viability relative to the untreated control group, is shown in Fig. 1 . Vehicle-treated cells and cells treated with 0.01 mg/ml propofol showed no significant differences compared with the untreated controls, whereas 0.1 mg/ml propofol led to significantly reduced cell viability after 48 h of treatment (-29.8 ± 5.3%, P < 0.05). Cell cultures treated with 1 mg/ml propofol displayed a significant decrease in cell viability after only 12 h (-17.9 ± 6.9%, P < 0.05), which became more accentuated after 24 h (-57.3 ± 5.9%, P < 0.001) and 48 h (-77.6 ± 4.0%, P < 0.001) compared with untreated controls. In contrast, short-term exposure to 1 mg/ml propofol led to significantly higher cell viability (+50.1 ± 12.1% after 3 h, P < 0.01; +22.6 ± 8.5% after 6 h, P < 0.05).
Light phase contrast photographs taken to illustrate the microscopical differences showed markedly affected cells after incubation with 1 mg/ml propofol for 24 h: control cell showed long processes with branching ( Fig. 2A) ; cells incubated with propofol were almost completely solved, cell bodies and processes were nearly lost (Fig. 2B ).
CELL VIABILITY AFTER PROPOFOL AND GABA A -RECEPTOR ANTAGONIST TREATMENTS
After 3, 6, 9 and 12 h treatment with 1 mg/ml propofol and the GABA A -receptor antagonists gabazine and picrotoxin, significant differences in cell viability were seen compared with that of treated control cells (treated only with 1 mg/ml propofol) (Fig. 3) . The early significant increase in cell viability of propofol-exposed cells was abrogated by both gabazine (from +50.1 to 
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+3.2% after 3 h, P < 0.01; from +31.8 to -5.6% after 6 h, P < 0.05) and picrotoxin (from +50.1 to -1.8% after 3 h, P < 0.01; from +31.8 to -17.8% after 6 h, P < 0.01). In addition, there was a significant reduction in cell viability with gabazine after 9 h (from +9.3 to -28.2%, P < 0.05), but not after 12 h, and with picrotoxin after 9 and 12 h (from +9.3 to -37.0% after 9 h, P < 0.01; from -19.9 to -65.8% after 12 h, P < 0.01) compared with cells treated with 1 mg/ml propofol alone. There were no significant differences 
EVALUATION OF TYPE OF CELL DEATH
Evaluation of the type of cell death after 24 h of treatment with 1 mg/ml propofol using the Cell Death Detection ELISA PLUS system revealed a statistically significant increase in the amount of apoptotic nucleosomes (Fig.  4) . Absorbance values of the incubation medium as a marker for necrotic cell death showed no significant differences compared with untreated controls.
Discussion
The present study showed that high concentrations of propofol (1 mg/ml) can cause an increase in neuronal cell viability after 3 and 6 h and a decrease from 12 h onwards. The addition of GABA A -receptor antagonists led to a significant reduction in cell viability after 3 -12 h of propofol treatment compared with cells incubated with 1 mg/ml propofol alone. The dominating mechanism of cell death was apoptosis, particularly in propofol-exposed cells.
The potential neuroprotective effect of propofol is consistent with many studies showing that anaesthetics can have protective effects against damaging factors. Three different explanations for the neuroprotective effects of anaesthetics have been proposed: (i) scavenging of free radicals, (ii) inhibition of glutamate release and (iii) potentiation of GABA A -mediated inhibition of synaptic transmission. 16 For propofol, increased uptake of glutamate, 17, 18 antioxidant properties (scavenging of peroxynitrite) 19, 20 and the crucial role of the GABA A receptor 21 have all been demonstrated. Although most studies have examined neuroprotective effects after ischaemic cerebral injury, the effect of propofol and other agents, such as barbiturates and volatile anaesthetics, seems to be mainly directed against excitotoxic injury. 16 In the present study, it was assumed that the standardized medium change at the beginning of each test, which is necessary in 
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order to apply the agent (e.g. propofol) to the culture, caused circumscribed cell death as a result of the changed chemical composition of the medium. 22, 23 Pre-treatment with the competitive GABA A -receptor antagonist gabazine and the non-competitive GABA Areceptor antagonist picrotoxin significantly inhibited the early neuroprotective effects of propofol and enhanced its later neurodegenerative effects, suggesting that GABA A receptors have an important role in propofol-induced neuroprotection.
The neurodegeneration seen after prolonged exposure to propofol correlates with previous reports identifying neuronal death as a consequence of high-dose propofol anaesthesia in neonatal rodents. Anaesthetics, sedatives and anti-epileptics that act via NMDA-receptor antagonism and/or GABA A -receptor agonism (such as ketamine, barbiturates, midazolam, isoflurane, nitrous oxide and propofol) have been shown to affect brain development in neonatal rodents. 2, 4, 5, 7, 8, 24 Accentuated GABA A -receptor agonism and a more distinctive NMDA-receptor antagonism have been described as the main mechanisms of action for propofol. 6, 25 Propofol-induced neurodegenerative effects, which also showed dose dependence, manifested as persistent behavioural deficits and a potentiation of neuronal cell death in studies performed in neonatal mice. 5 Clinically relevant concentrations of propofol caused a dosedependent loss of GABAergic neurons and impairment of dendritic arbour development in primary cultures from newborn rat cerebral cortex. 26, 27 In a study with chick explant cultures, supraclinical concentrations of propofol induced neurite retractions and growth cone collapse. 28 In addition, several studies have demonstrated much more severe neurodegeneration triggered by combinations of anaesthetics, including thiopental plus propofol, ketamine plus propofol, midazolam plus ketamine, and diazepam plus phenobarbital. 2, 5, 8 GABAergic neurons in rat brain cell co-cultures have been shown to display vulnerability to propofol administration, in contrast to glial cells. 29 High-dose propofol or the combination of ketamine and propofol was shown to increase apoptosis measured with Fluoro-Jade staining in mice brains. 5 In the present study, the results of the Cell Death Detection ELISA PLUS system argue for the dominance of an apoptotic mechanism and are, therefore, consistent with other studies. 5, 30 An assumed GABA potentiation, which would lead to excessive neuronal inhibition and neuronal redundancy resulting in apoptosis, is unlikely in the light of the GABA A -receptor independence of the neurodegenerative effect of propofol shown in the present study. The design of the present study does not allow conclusions concerning the mechanism of cell death; further investigations are needed to find out whether low doses of propofol lead to apoptosis and high doses to necrotic death, depending on exposure time.
The propofol concentrations used in the present study are very high compared with clinical levels and there is currently no clear evidence of a concentration limit for the effects seen. After anaesthesia with propofol at a dose of 2 mg/kg body weight and a maintenance dosage of 8 mg/kg body weight per h, a plasma concentration of 2.24 µg/ml after 5 min and a cerebrospinal fluid concentration of 35.5 ng/ml after 15 -30 min were measured in human adults. 31 It is important to take into account the increased vulnerability of the immature brain to neuronal apoptosis or to neurodegenerative mechanisms caused by natural reorganization, 32 34 Furthermore, there are no data available on the potential for propofol accumulation in human brain tissue after long-term exposure. The neurodegeneration seen in the present study at high propofol concentrations after 12 h corresponds to the clinical findings seen in critically ill children who develop propofol-infusion syndrome. 11, 35 In these cases, the clinical manifestations are metabolic acidosis, bradycardia and progressive myocardial failure after infusion of a high dose of propofol (> 4 mg/kg per day) for ≥ 48 h. Even though the present study was carried out in neuronal cell culture, the results may be an additional indicator that propofol should be used with caution for long-term sedation and high doses should be avoided in infants.
The advantage of using a primary neuronal culture is the high survival of plated cells in serum-free B27/neurobasal medium. 13 In addition, the use of primary neuronal cultures from rat embryos allows study of the neurodegenerative effects on developing neurons. However, since the examined cells are considered to be mature after 15 days in vitro, further studies should be performed using more immature cells.
This study demonstrated for the first time a combination of time-dependent neuroprotection and neurodegeneration when propofol was applied to primary embryonic cultures. Further investigations such as Western blot analysis of the activation of caspases are needed to identify the underlying mechanism of neuronal damage and determine to what extent established anaesthetic procedures may pose a significant risk to the developing human brain.
